RosVivo Therapeutics Overview

Life ScienceCompany

Where is RosVivo Therapeutics headquartered?

RosVivo Therapeutics is headquartered in Reno, Nevada.

What sector is RosVivo Therapeutics in?

RosVivo Therapeutics is a life science company.

RosVivo Therapeutics

RosVivo Therapeutics, Inc.

450 Sinclair Street,
Reno, Nevada 89501
United States,
(775) 409-6007
www.rosvivo.com

RosVivo Therapeutics targets diseases with breakthrough therapies utilizing microRNA (miRNA) and small interfering-RNA (siRNA) drugs. Discovery research conducted by Dr. Seungil Ro’s laboratory recently identified key miRNAs responsible for the onset and development of Type 2 Diabetes (T2D). Preclinical studies show depletion of these key miRNAs leads to the development of not only T2D, but also obesity, fatty acid liver disease, hyperlipidemia, and gastroparesis. Remarkably, restoration of these miRNAs reverses these disease states. RosVivo Therapeutics is unique in that the miRNA drugs are developed will help rescue several metabolic disease states not just alleviate symptoms. RosVivo Therapeutics is based in Reno, Nevada.



Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.